 |
市場調查報告書
商品編碼
1396138
全球獸醫腫瘤市場規模、佔有率、成長分析（依治療方法、動物類型、癌症類型）- 產業預測，2023-2030 年Global Veterinary Oncology Market Size, Share, Growth Analysis, By Therapy(Surgery, Radiotherapy), By Animal type(Canine, and Feline), By Cancer Type(Lymphoma, Mast Cell Cancer) - Industry Forecast 2023-2030 |
||||||
2021年獸醫腫瘤市場規模為2062.4億美元，從2022年的2314億美元成長到2030年的5779億美元，預測期內（2023-2030）複合年成長率為12.10，預計成長% 。
獸醫腫瘤治療市場的成長主要是由於動物群體中癌症盛行率的增加以及擴大採用獸醫癌症治療作為治療方式所推動的。寵物飼主投資動物保健的意願增強以及政府支持獸醫癌症治療的舉措等因素對市場擴張做出了重大貢獻。特別是，新興經濟體的獸醫保健支出正在迅速增加，美國獸醫協會 (AVMA) 等組織的預測表明，很大一部分狗可能會患上腫瘤。美國動物醫院協會 (AAHA) 報告將腫瘤疾病列為狗死亡的主要原因，強調由於癌症發病率不斷增加，需要改進獸醫腫瘤治療。貓科動物群體，特別是那些持有貓白血病病毒（FeLV）的貓科動物，已被確定為貓淋巴瘤的重要來源，這進一步凸顯了對加強獸醫腫瘤學解決方案的需求。 COVID-19 大流行影響了寵物飼主與其動物之間的關係，增加了被關起來時的親密感。隨著人們回歸常態，寵物人性化的趨勢，即寵物融入日常生活和寵物友善的環境中，預計將支持市場成長。此外，評估各種寵物腫瘤治療的有效性和安全性的獸醫臨床研究的迅速增加也有助於市場的擴張。 AVMA 動物健康研究資料庫 (AAHSD) 等舉措使研究人員更容易進行前瞻性獸醫臨床研究，從而提高獸醫腫瘤學知識。政府的支持，例如美國癌症研究所 (NCI) 資助獸用抗癌藥物臨床試驗的努力，正在進一步推動該產業的發展。這些臨床試驗旨在發現新的癌症治療方法，同時保持動物的生活品質。獸醫癌症治療和在狗身上測試的技術應用於人類癌症治療的潛力為市場的成長軌跡增添了新的方面。
本報告的目標區隔市場
全球獸醫腫瘤學市場根據治療方法、動物類型、癌症類型和地區進行區隔。依治療方法，市場分為手術、放射線治療、化療、免疫療法等。根據動物類型，市場分為狗和貓。根據癌症類型，市場分為淋巴瘤、肥大細胞癌、乳癌、鱗狀細胞癌等。依地區分類，全球獸醫癌症市場分為北美、歐洲、亞太地區、南美洲和中東和非洲。
促進因素
癌症發生率增加
由於伴同性動物（尤其是狗和貓）癌症發生率的增加，獸醫腫瘤學市場正在見證成長。寵物和人類一樣，壽命更長，因此罹患癌症的可能性隨著老齡化的成長而增加。這一趨勢促使獸醫領域對有效腫瘤治療的需求不斷成長。
抑制因素
與獸醫腫瘤治療相關的費用
對於許多寵物主人來說，與獸醫腫瘤治療相關的費用是一個重大限制。癌症治療通常包括昂貴的組成部分，例如診斷程序、手術、藥物和持續護理。這種財務負擔可能會限制獸醫腫瘤學服務的可近性和可負擔性。
市場趨勢：
人們對醫療保健的興趣日益濃厚
獸醫腫瘤學領域正在迅速採用個人化醫療，反映了人類腫瘤學的趨勢。該策略根據每隻動物獨特的癌症特徵（例如基因突變和生物標記）量身定做治療計劃。獸醫腫瘤學個人化醫療的目標是改善治療結果，同時最大限度地減少副作用。
免疫療法的成長
免疫療法是獸醫腫瘤學領域的主要趨勢，並呈現出顯著的成長趨勢。這種方法透過使用疫苗、免疫查核點抑制劑和其他免疫調節劑來刺激或增強對癌細胞的免疫反應，利用人體的免疫系統來對抗癌症。免疫療法已顯示出有希望的結果，並且正在動物身上積極研究各種類型的癌症。
標靶治療的興起
標靶治療的出現是獸醫腫瘤學的顯著發展。這些療法是專門針對癌細胞及其分子途徑而設計的，目的是抑制癌細胞的生長和存活，同時最大限度地減少對健康細胞的傷害。獸醫腫瘤學中對標靶治療的日益關注正在引入副作用更少的新治療方法。
先進的診斷整合
先進成像技術的整合在獸醫腫瘤學實踐中變得越來越普遍。正子斷層掃描 (PET)、電腦斷層掃描 (CT) 和磁振造影(MRI) 是廣泛使用的技術。這些先進的影像工具提供詳細的腫瘤可視化，以實現準確的分期、治療計劃和持續監測治療效果。
目錄
- 執行摘要
- 調查方法
- 母市場分析
- 主要市場考察
- 技術分析
- 價格分析
- 供應鏈分析
- 價值鏈分析
- 市場生態系統
- 智慧財產權分析
- 貿易分析
- Start-Ups分析
- 原料分析
- 創新矩陣
- 研發線產品分析
- 總體經濟指標
- 主要投資分析
- 關鍵成功因素
- 競爭程度
- 市場動態及展望
- 市場動態
- 促進因素
- 機會
- 抑制因素
- 任務
- 監管形勢
- 波特的分析
- 對未來中斷的特殊考察
- 市場動態
- 全球獸醫腫瘤學市場：依治療分類
- 市場概況
- 外科手術
- 放射線治療
- 化療
- 免疫療法
- 其他
- 全球獸醫腫瘤學市場：依動物類型
- 市場概況
- 犬科動物
- 貓科動物
- 全球獸醫腫瘤學市場：依癌症類型
- 市場概況
- 淋巴瘤
- 肥大細胞癌
- 乳癌/鱗狀細胞癌
- 其他
- 全球獸醫腫瘤學市場規模（依地區）
- 市場概況
- 北美洲
- 美國
- 加拿大
- 歐洲
- 德國
- 西班牙
- 法國
- 英國
- 其他歐洲國家地區
- 亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
- 拉丁美洲
- 巴西
- 其他拉丁美洲地區
- 中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區
- 競爭形勢
- 前5名企業對比
- 主要企業市場定位（2021年）
- 主要市場參與者所採取的策略
- 關鍵成功策略
- 近期市集活動
- 主要企業市場佔有率（2021年）
- 主要企業簡介
- Zoetis
- Elanco Animal Health
- IDEXX Laboratories
- Veterinary Cancer Group
- Ethos Veterinary Health
- VCA（Veterinary Centers of America）
- BluePearl Veterinary Partners
- Anivive Lifesciences
- Aratana Therapeutics（Part of Elanco Animal Health）
- Oncolytics Biotech Inc.
- VetDC
- Rhizen Pharmaceuticals
- AB Science
- VetCell Therapeutics
- Vet-Stem, Inc.
- Nexvet（Part of Zoetis）
- Pegasus Laboratories（Part of Merck Animal Health）
- Biomedica Management Corporation
- Sentinel Biomedical
- Karyopharm Therapeutics
Veterinary Oncology Market size was valued at USD 206.24 billion in 2021 and is poised to grow from USD 231.4 billion in 2022 to USD 577.9 billion by 2030, growing at a CAGR of 12.10% in the forecast period (2023-2030).
The growth of the veterinary cancer therapy market is primarily driven by the increasing incidence of cancer in the animal population and the growing adoption of veterinarian cancer therapy as a treatment modality. Factors such as the rising willingness of pet owners to invest in animal healthcare and government initiatives supporting veterinary cancer therapy contribute significantly to market expansion. Notably, developed economies are witnessing a surge in spending on animal healthcare, with predictions from organizations like the American Veterinary Medical Association (AVMA) indicating a high likelihood of neoplasia in a substantial proportion of dogs. Reports from the American Animal Hospital Association (AAHA) highlight neoplastic disease as a leading cause of mortality in dogs, emphasizing the need for improved veterinary oncology treatments due to the increasing incidence of cancer. The feline population, particularly those carrying the feline leukemia virus (FeLV), has been identified as a significant source of lymphoma in cats, further underscoring the demand for enhanced veterinary oncology solutions. The COVID-19 pandemic has influenced the relationship between pet owners and their animals, with increased closeness observed during lockdowns. As people return to normalcy, the trend of pet humanization, where pets are integrated into everyday routines and pet-friendly environments, is expected to support market growth. Additionally, the surge in veterinary clinical studies evaluating the effectiveness and safety of various oncologic treatments for pets is contributing to market expansion. Initiatives like the AVMA Animal Health Research Database (AAHSD) facilitate researchers in conducting prospective veterinary clinical studies, thereby advancing knowledge in veterinary oncology. Government support, exemplified by initiatives such as the National Cancer Institute (NCI) funding trials for veterinary oncology medicines, further propels the industry. These trials aim to discover novel cancer treatments while maintaining the quality of life for animals. The convergence of veterinary oncology treatments and techniques, tested in dogs, with potential applications in human cancer treatment adds another dimension to the market's growth trajectory.
Segments covered in this report
The global veterinary oncology market is categorized on the basis of therapy, animal type, cancer type, and region. Based on therapy, the market is segmented into surgery, radiotherapy, chemotherapy, immunotherapy, and others. Based on animal type, the market is segmented into canine, and feline. Based on cancer type, the market is segmented into lymphoma, mast cell cancer, mammary and Squamous cell cancer, and others. Based on region the global veterinary oncology market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.
Drivers:
Increasing Incidence of Cancer
The veterinary oncology market is witnessing growth due to the increasing occurrence of cancer in companion animals, notably dogs and cats. As pets experience extended lifespans, similar to humans, the likelihood of cancer development rises with age. This trend contributes to a growing demand for efficient oncology treatments in the veterinary sector.
Restraints:
Expense associated with veterinary oncology treatments
The expense associated with veterinary oncology treatments poses a notable constraint for numerous pet owners. Cancer treatments often encompass costly elements such as diagnostic procedures, surgeries, medications, and ongoing care. This financial burden may restrict the accessibility and affordability of veterinary oncology services.
Market Trends:
Increasing Focus on Medicine
The field of veterinary oncology is experiencing a surge in the adoption of personalized medicine, mirroring a trend observed in human oncology. This strategy involves customizing treatment plans based on specific characteristics unique to an individual animal's cancer, such as genetic mutations or biomarkers. The goal of personalized medicine in veterinary oncology is to enhance treatment outcomes while minimizing adverse effects.
Growth of Immunotherapy
Immunotherapy is gaining significant traction in the realm of veterinary oncology, showcasing a notable growth trend. This approach harnesses the body's immune system to combat cancer, employing vaccines, immune checkpoint inhibitors, and other immunomodulatory agents to stimulate or enhance the immune response against cancer cells. Immunotherapy is demonstrating promising results and is actively explored for various types of cancers in animals.
Rise in Targeted Therapies
The emergence of targeted therapies is a noteworthy development in veterinary oncology. These therapies are specifically designed to target cancer cells or their molecular pathways, aiming to disrupt cancer cell growth and survival while minimizing harm to healthy cells. The increasing focus on targeted therapies in veterinary oncology is introducing new treatment options that hold the potential for fewer side effects.
Integration of Advanced Diagnostic
The integration of advanced diagnostic imaging techniques is becoming more prevalent in veterinary oncology practices. Modalities such as positron emission tomography (PET), computed tomography (CT), and magnetic resonance imaging (MRI) are being extensively employed. These advanced imaging tools provide detailed visualization of tumors, aiding in accurate staging, treatment planning, and the ongoing monitoring of treatment responses.
Table of Contents
- Executive Summary
- Market Overview
- Wheel of Fortune
- Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
- Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
- Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
- Market Dynamics
- Global Veterinary Oncology Market by Therapy
- Market Overview
- Surgery
- Radiotherapy
- Chemotherapy
- Immunotherapy
- and Others
- Global Veterinary Oncology Market by Animal type
- Market Overview
- Canine
- and Feline
- Global Veterinary Oncology Market by Cancer Type
- Market Overview
- Lymphoma
- Mast Cell Cancer
- Mammary and Squamous Cell Cancer
- and Others
- Global Veterinary Oncology Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
- Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
- Key Company Profiles
- Zoetis
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Elanco Animal Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- IDEXX Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Veterinary Cancer Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ethos Veterinary Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- VCA (Veterinary Centers of America)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BluePearl Veterinary Partners
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Anivive Lifesciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Aratana Therapeutics (Part of Elanco Animal Health)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Oncolytics Biotech Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- VetDC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Rhizen Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AB Science
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- VetCell Therapeutics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Vet-Stem, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nexvet (Part of Zoetis)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Pegasus Laboratories (Part of Merck Animal Health)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Biomedica Management Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sentinel Biomedical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Karyopharm Therapeutics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Zoetis
獸醫腫瘤市場市場規模、佔有率、趨勢分析報告：按治療、按動物類型、按癌症類型、按地區、細分市場預測，2024-2030 年
全球獸醫腫瘤市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測
北美獸醫腫瘤市場規模、佔有率、趨勢分析報告：按動物類型、治療方法、癌症類型、國家、細分市場預測，2023-2033 年
獸醫腫瘤學市場：治療（化療、免疫療法、放射療法）、動物類型（狗、貓）、癌症類型-俄烏衝突和高通貨膨脹-全球預測2023-2030
獸醫腫瘤學的全球市場
獸醫腫瘤學市場:各動物類型，各治療類型，劑型，各用途，各流通管道，各地區- 規模，佔有率，展望，機會分析，2022年～2030年
全球獸醫腫瘤學市場：按治療、動物、癌症和地區劃分的市場規模和預測（2022-2028 年）